[{"address1": "5401 West Kennedy Boulevard", "address2": "Suite 890", "city": "Tampa", "state": "FL", "zip": "33609", "country": "United States", "phone": "813 553 6680", "website": "https://www.pacira.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature to targeted nerves. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.", "fullTimeEmployees": 711, "companyOfficers": [{"maxAge": 1, "name": "Mr. Charles A. Reinhart III, CPA, M.B.A.", "age": 62, "title": "Chief Financial Officer", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 720291, "exercisedValue": 0, "unexercisedValue": 22240}, {"maxAge": 1, "name": "Mr. Daryl  Gaugler", "age": 61, "title": "Chief Operating Officer", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 747920, "exercisedValue": 12700, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kristen  Williams J.D.", "age": 49, "title": "Chief Administrative Officer & Secretary", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 738520, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David M. Stack", "age": 73, "title": "Advisor", "yearBorn": 1950, "fiscalYear": 2023, "totalPay": 1701507, "exercisedValue": 0, "unexercisedValue": 83400}, {"maxAge": 1, "name": "Dr. Jonathan  Slonin M.D.", "age": 48, "title": "Chief Medical Officer", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 730872, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Frank D. Lee", "age": 55, "title": "CEO & Director", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lauren Bullaro Riker", "age": 44, "title": "Principal Accounting Officer & Senior VP of Finance", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 288815, "exercisedValue": 196600, "unexercisedValue": 1271722}, {"maxAge": 1, "name": "Susan  Mesco", "title": "Head of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Anthony  Molloy III, Esq.", "age": 49, "title": "Chief Legal & Compliance Officer", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 581410, "exercisedValue": 802073, "unexercisedValue": 3099}, {"maxAge": 1, "name": "Mr. Richard  Kahr", "title": "Vice President of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 1, "boardRisk": 5, "compensationRisk": 4, "shareHolderRightsRisk": 9, "overallRisk": 5, "governanceEpochDate": 1719792000, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 22.74, "open": 21.7, "dayLow": 21.405, "dayHigh": 22.5677, "regularMarketPreviousClose": 22.74, "regularMarketOpen": 21.7, "regularMarketDayLow": 21.405, "regularMarketDayHigh": 22.5677, "beta": 0.88, "trailingPE": 14.344371, "forwardPE": 6.0502796, "volume": 1044200, "regularMarketVolume": 1044200, "averageVolume": 926224, "averageVolume10days": 1888640, "averageDailyVolume10Day": 1888640, "marketCap": 1008188544, "fiftyTwoWeekLow": 20.52, "fiftyTwoWeekHigh": 40.16, "priceToSalesTrailing12Months": 1.4788158, "fiftyDayAverage": 28.501, "twoHundredDayAverage": 29.54665, "currency": "USD", "enterpriseValue": 1264076544, "profitMargins": 0.103369996, "floatShares": 46057413, "sharesOutstanding": 46546100, "sharesShort": 6361378, "sharesShortPriorMonth": 6040587, "sharesShortPreviousMonthDate": 1715731200, "dateShortInterest": 1718323200, "sharesPercentSharesOut": 0.1367, "heldPercentInsiders": 0.01584, "heldPercentInstitutions": 1.09652, "shortRatio": 10.08, "shortPercentOfFloat": 0.1983, "impliedSharesOutstanding": 46546100, "bookValue": 19.179, "priceToBook": 1.1293602, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": 70470000, "trailingEps": 1.51, "forwardEps": 3.58, "pegRatio": 0.81, "enterpriseToRevenue": 1.854, "enterpriseToEbitda": 7.532, "52WeekChange": -0.4283452, "SandP52WeekChange": 0.25871396, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "PCRX", "underlyingSymbol": "PCRX", "shortName": "Pacira BioSciences, Inc.", "longName": "Pacira BioSciences, Inc.", "firstTradeDateEpochUtc": 1296743400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "050afc8c-af85-375d-b389-8ab4bab1ead0", "messageBoardId": "finmb_27508", "gmtOffSetMilliseconds": -14400000, "currentPrice": 21.66, "targetHighPrice": 57.0, "targetLowPrice": 25.0, "targetMeanPrice": 44.7, "targetMedianPrice": 44.0, "recommendationMean": 1.8, "recommendationKey": "buy", "numberOfAnalystOpinions": 10, "totalCash": 325889984, "totalCashPerShare": 7.001, "ebitda": 167820000, "totalDebt": 581777024, "quickRatio": 4.576, "currentRatio": 5.812, "totalRevenue": 681753984, "debtToEquity": 65.21, "revenuePerShare": 14.706, "returnOnAssets": 0.03759, "returnOnEquity": 0.08489, "freeCashflow": 146279120, "operatingCashflow": 184622000, "revenueGrowth": 0.042, "grossMargins": 0.61801, "ebitdaMargins": 0.24615999, "operatingMargins": 0.090450004, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-07-05"}]